Santarus | Evaluate

August 12, 2016

Interview – Pharming’s last chance lies with solo strategy

November 07, 2014

Salix ruins its reputation with disastrous inventory admissions

July 11, 2014

Upcoming events: Alzheimer’s conference and US action on Ruconest

July 09, 2014

Ireland tax shelter beckons for Salix

July 02, 2014

Salix’s persistence pays off with IBS confirmation

April 07, 2014

Big pharma benefits from biotech carnage in Q1

November 08, 2013

Salix plays the long game with $2.6bn Santarus swoop

August 02, 2013

BioCryst eyes HAE market as Viropharma struggles to innovate

January 15, 2013

Uceris approval kicks off what could be a record year for Santarus

January 09, 2013

Sarepta joins the big league as best-performing 2012 share

December 24, 2012

Event – Santarus needs Uceris approval to boost flagging pipeline

Load More